NDAORALTABLET
Approved
Feb 2020
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
4/8 — Partial
ADVIL DUAL ACTION WITH ACETAMINOPHEN (ibuprofen, acetaminophen) by GSK is cyclooxygenase inhibitors [moa]. First approved in 2020.
Drug data last refreshed 2m ago · AI intelligence enriched 2m ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ADVIL DUAL ACTION WITH ACETAMINOPHEN is an oral tablet combining ibuprofen (NSAID) and acetaminophen for pain and inflammation relief. It works by inhibiting cyclooxygenase enzymes to reduce prostaglandin production and alleviate pain. This fixed-dose combination targets consumers seeking enhanced analgesic efficacy through dual mechanisms.
Peak14.8 years to LOE
Peak lifecycle stage indicates mature commercial organization with stable team size; optimization and defense against generics are primary focus areas.
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ADVIL DUAL ACTION positions you in a mature, peak-stage OTC brand with strong consumer recognition and an extended patent runway. Career opportunities center on commercial strategy, market defense, and brand optimization rather than clinical development or novel indication expansion.
Brand ManagerField Sales Representative
Worked on ADVIL DUAL ACTION WITH ACETAMINOPHEN at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.